Endovascular therapies such as stenting have been widely adopted to treat peripheral artery disease in the lower extremity. Peripheral vascular stents including bare metal, drug-eluting, covered and bioabsorbable stents are associated with improved clinical outcomes compared to balloon angioplasty alone.

The global peripheral vascular stent (PVS) market is steadily growing in the 10 countries covered in the report, including the US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India.

Browse full report with TOC @   

Through GlobalData’s analysis, it is evident that currently the peripheral vascular stent market for the lower extremity is saturated with bare metal stents, followed by covered stents. However, as clinical data and appropriate reimbursement and costs are established, adoption of innovative stent technologies such as drug-eluting stents and bioabsorbable stents will increase in the future.

By the end of the forecast period, the competitive landscape will experience significant change due to the launch of bioabsorbable stents in the market, the expansion of approved indications to include infrapopliteal artery lesions and the entry of new companies such as 480 Biomedical.

Questions Answered in this Report

What is the current perception and adoption of vascular stents for treating indications, including the iliac, femoropopliteal and infrapopliteal arteries in the lower extremity?
Bare metal and covered stents have been on the market for many years; however, unmet needs still exist with respect to patency and restenosis and treating challenging lesions in the femoropopliteal and infrapopliteal arteries. How will drug-eluting and bioabsorbable stents fulfil the unmet needs of the peripheral stent market for the lower extremity?
What is the current perception and adoption of innovative stent platforms such as drug-eluting and bioabsorbable stents in the major markets? How will adoption of these stent technologies affect adoption of bare metal and covered stents?
A majority of pipeline products are drug-eluting bioabsorbable stents. As more bioabsorbable stents receive approval, how will new entrants impact the peripheral vascular stent market for the lower extremity?
The global PVS market for the lower extremity is forecast to steadily increase in the future. What are the key factors and opportunities that will drive the market in terms of future adoption rates leading to a mature market?
Regions Covered: US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India.

View all reports of this category @        

Market Model Features

An interactive excel forecast model based on primary research interviews and surveys with KOLs, physicians, industry participants and distributors is included in this report*. The forecast model is robust, fully transparent, and easy to navigate. Moreover, our models support data presented in the reports and the complete methodology is outlined in the report and the model.

*Interactive excel forecast model only available to clients purchasing a site license or higher.

For More Information Click Here – Acute Market Reports

About Acute Market Reports

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements. Acute Market Reports provide online reports from over 100 best publishers and upgrade Acute Market Reports collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends. Acute Market Reports database consists of 200,000+ market research reports with detailed & minute market research


Chris Paul

Office No 01, 1st Floor,

Aditi Mall, Baner, Pune,

MH, 411045 India

Phone (India): +91 7755981103

Toll Free (US/Canada): +1-855-455-8662